Delpazolid not checked
LigaChem Biosciences, Inc. · LCB01-0371
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
5 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Delpazolid is not licensed yet. Current experience in humans upto Phase IIA. Dose according to randomization to dosing arms 2-5.”In the company’s words, NCT04550832 on ClinicalTrials.gov
- Tested for
- Infections and Infestations, Pulmonary Tuberculosis, MRSA Bacteremia, Nontuberculous Mycobacterium Infection, Mycobacterium Abscessus Infection
- Main trialPhase 2
- “This trial is to describe the safety, tolerability and exposure-toxicity relationship of Depazolid given over 16 weeks, in combination with standard-dose Bedaquiline, Delamanid and Moxifloxacin, compared to standard-dose Bedaquiline, Delamanid and Moxifloxacin alone”In the company’s words, NCT04550832 on ClinicalTrials.gov
- Other names
- LCB01-0371
Other drugs for Pulmonary Tuberculosis
- SudapyridineShanghai Jiatan Pharmatech Co., Ltd · Phase 3
- RESP30TBThirty Respiratory Limited · Phase 2
- QTP101Quratis Inc. · Phase 1
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Completed | 4 Jan 2023 | PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE) | |
| Phase 2Terminated | 21 Feb 2024 | A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia | |
| Phase 2Completed | 15 Sep 2025 | Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex | |
| Phase 1Completed | 3 Aug 2020 | A Mass Balance Study of LCB01-0371 After a Single Oral LCB01-0371 Dose With a [14C]LCB01-0371-microtrace | |
| Phase 1Completed | 24 Jan 2021 | Trial to Evaluate Bioequivalence of LCB01-0371 in Different Batches |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026